SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page89101112131415Next Page
2026-06-17MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 4584 units of Mineralys Therapeutics, Inc. securities around 2026-06-17, with aggregate market value of $114,600.00. The total outstanding units is 82498101.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
Previous Page89101112131415Next Page